Smoking is a known lung cancer cause, but no detailed quantitative systematic review exists
Results are selected for: sex – single sex results, combined sex results; adjustment for potential confounders – most available. b n = number of estimates combined, F = fixed-effect meta-analysis relative risk), R = random-effects meta-analysis RR, H = heterogeneity chisquared per degree of freedom, PH = probability value for heterogeneity expressed as p < 0.001, p < 0.01, p < 0.05, p < 0.1 or NS, PE = probability value for Egger’s test of publication bias expressed, PB = probability value for between levels expressed. c All or nearest available, must include at least squamous cell carcinoma and adenocarcinoma. d Squamous cell carcinoma or nearest available, but not including adenocarcinoma. e Adenocarcinoma or nearest available, but not including squamous cell carcinoma. f Or nested case–control or case-cohort in the case of 5 estimates for all lung cancer, 4 for squamous and 4 for adeno. g Or not known in the case of 10 estimates for all lung cancer, 2 for squamous, and 2 for adeno. h In the study as a whole
A Within each study, results for the relevant smoking product and smoking status are selected in the following preference order, within each sex, for: cigarette type – see notes f to i; unexposed group – see notes f to i; smoking product – any, cigarettes, cigarettes only; smoking status – ever, current; lung cancer type – see notes c to e; race – all or nearest available, otherwise by race; follow-up period – longest available; overlapping studies – principal, subsidiary; age – whole study, widest available age group; Results are selected for: sex – single sex results, combined sex results; adjustment for potential confounders – most available. b n = number of estimates combined, F = fixed-effect meta-analysis RR, R = random-effects meta-analysis RR, H = heterogeneity chisquared per degree of freedom, PH = probability value for heterogeneity expressed as p < 0.001, p < 0.05, p < 0.1 or NS, PB = probability value for between levels expressed. c All or nearest available, must include at least squamous cell carcinoma and adenocarcinoma. d Squamous cell carcinoma or nearest available, but not including adenocarcinoma. e Adenocarcinoma or nearest available, but not including squamous cell carcinoma. f Or nearest available
Our analyses showed that for all lung cancer, risk increased with increasing tar level and with increasing fraction smoked, data here being more limited and non existent by histological type
After excluding studies involving less than 100 lung cancer cases, we identified 287 epidemiological studies of lung cancer which provided information on risk in relation to one or more of a defined list of smoking indices
Of the 267 independent principal studies, 262 provided RRs relating to all lung cancer, 84 provided RRs relating to squamous cell carcinoma, and 86 provided RRs relating to adenocarcinoma
One major conclusion is that for each outcome the relative risk for all major smoking indices were markedly heterogeneous
Need more features? Save interactive summary cards to your Scholarcy Library.